This HTML5 document contains 144 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n22https://dblp.org/pid/15/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n24http://commons.wikimedia.org/wiki/Special:FilePath///news.engineering.utoronto.ca/files/2016/05/
n21http://www.psi.toronto.edu/~frey/
n14https://global.dbpedia.org/id/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
n20http://dl.acm.org/
n25http://news.engineering.utoronto.ca/files/2016/05/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n18http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n17https://scholar.google.ca/
freebasehttp://rdf.freebase.com/ns/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
n10https://web.archive.org/web/20151120093311/http:/www.cifar.ca/
wikidatahttp://www.wikidata.org/entity/
goldhttp://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Brendan_Frey
rdf:type
wikidata:Q901 wikidata:Q19088 dbo:Species schema:Person dbo:Animal dbo:Scientist n18:NaturalPerson dbo:University wikidata:Q215627 wikidata:Q729 dbo:Eukaryote wikidata:Q5 foaf:Person dbo:Person owl:Thing
rdfs:label
Brendan Frey
rdfs:comment
Brendan John Frey FRSC (born 29 August 1968) is a Canadian-born entrepreneur, engineer and scientist. He is Founder and CEO of Deep Genomics, Cofounder of the Vector Institute for Artificial Intelligence and Professor of Engineering and Medicine at the University of Toronto. Frey is a pioneer in the development of machine learning and artificial intelligence methods, their use in accurately determining the consequences of genetic mutations, and in designing medications that can slow, stop or reverse the progression of disease.
foaf:name
Brendan Frey
foaf:homepage
n21:
dbp:name
Brendan Frey
foaf:depiction
n24:Frey_600x400.jpg
dbo:birthDate
1968-08-29
dcterms:subject
dbc:Fellows_of_the_Royal_Society_of_Canada dbc:Living_people dbc:1968_births dbc:University_of_Toronto_faculty
dbo:wikiPageID
44778625
dbo:wikiPageRevisionID
981379954
dbo:wikiPageWikiLink
dbr:Medications dbr:Microsoft_Research dbr:Graphical_model dbr:Royal_Society_of_Canada dbr:Banting_and_Best_Department_of_Medical_Research dbr:Canada dbr:Neural_network dbr:Drug_candidate dbr:Cambridge_University dbr:University_of_Toronto dbc:Fellows_of_the_Royal_Society_of_Canada dbr:Affinity_Propagation dbr:Digital_communications dbr:Terrence_Donnelly_Centre_for_Cellular_and_Biomolecular_Research dbr:Bell-Northern_Research dbr:Deep_learning dbr:University_of_Calgary dbr:Isaac_Newton_Institute_for_Mathematical_Sciences dbr:Darwin_College,_Cambridge dbr:University_of_Waterloo dbr:Cavendish_Laboratory dbr:Wake-sleep_algorithm dbr:Geoffrey_Hinton dbr:Exponential_growth dbr:Machine_learning dbr:John_C._Polanyi dbr:Affinity_propagation dbc:Living_people dbr:University_of_Manitoba dbr:Wake-Sleep_Algorithm dbr:Computer_vision dbr:University_of_Illinois_at_Urbana_Champaign dbr:Genome_biology dbr:Beckman_Fellow dbr:Speech_recognition dbr:Factor_graph dbc:1968_births dbr:Factor_Graphs dbr:Artificial_intelligence dbc:University_of_Toronto_faculty dbr:Computer_engineering dbr:Mutations dbr:University_of_Illinois
dbo:wikiPageExternalLink
n10:brendan-j-frey-gne n17:citations%3Fuser=RjQ7YnMAAAAJ&hl=en n21: n25:Frey_600x400.jpg n20:citation.cfm%3Fid=289988
owl:sameAs
freebase:m.012hf3wh n14:oEFh wikidata:Q18684996 n22:1159 yago-res:Brendan_Frey
dbp:thesisTitle
Graphical Models for Machine Learning and Digital Communication
dbp:thesisUrl
n20:citation.cfm%3Fid=289988
dbp:thesisYear
1997
dbp:workplaces
University of Illinois Bell-Northern Research Deep Genomics Inc University of Waterloo University of Toronto
dbp:wikiPageUsesTemplate
dbt:Small dbt:Authority_control dbt:Reflist dbt:Infobox_scientist dbt:Birth_date_and_age
dbo:thumbnail
n24:Frey_600x400.jpg?width=300
dbp:almaMater
University of Toronto
dbp:awards
John C. Polanyi FRSC
dbp:birthDate
1968-08-29
dbp:birthName
Brendan John Frey
dbp:fields
Machine learning Genome biology Computer engineering
dbp:knownFor
Deep Genomics Inc Genome biology Vector Institute Wake-Sleep Algorithm First Drug Discovered by AI Affinity Propagation Factor Graphs
dbp:residence
dbr:Canada
dbp:website
n21:
dbo:abstract
Brendan John Frey FRSC (born 29 August 1968) is a Canadian-born entrepreneur, engineer and scientist. He is Founder and CEO of Deep Genomics, Cofounder of the Vector Institute for Artificial Intelligence and Professor of Engineering and Medicine at the University of Toronto. Frey is a pioneer in the development of machine learning and artificial intelligence methods, their use in accurately determining the consequences of genetic mutations, and in designing medications that can slow, stop or reverse the progression of disease. As far back as 1995, Frey co-invented one of the first deep learning methods, called the wake-sleep algorithm, the affinity propagation algorithm for clustering and data summarization, and the factor graph notation for probability models. In the late 1990s, Frey was a leading researcher in the areas of computer vision, speech recognition, and digital communications. In 2002, a personal crisis led Frey to face the fact that there was a tragic gap between our ability to measure a patient's mutations and our ability to understand and treat the consequences. Recognizing that biology is too complex for humans to understand, that in the decades to come there would be an exponential growth in biology data, and that machine learning is the best technology we have for discovering relationships in large datasets, Frey set out to build machine learning systems that could accurately predict genome and cell biology. His group pioneered much of the early work in the field and over the next 15 years published more papers in leading-edge journals than any other academic or industrial research lab. In 2015, Frey founded Deep Genomics, with the goal of building a company that can produce effective and safe genetic medicines more rapidly and with a higher rate of success than was previously possible. The company has received 60 million dollars in funding to date from leading Bay Area investors, including the backers of SpaceX and Tesla. In 2019, Deep Genomics became the first company to announce a drug candidate that was discovered by artificial intelligence.
dbp:doctoralAdvisor
dbr:Geoffrey_Hinton
dbo:doctoralAdvisor
dbr:Geoffrey_Hinton
dbo:institution
dbr:University_of_Toronto dbr:Bell-Northern_Research dbr:University_of_Illinois dbr:University_of_Waterloo
gold:hypernym
dbr:Learning
prov:wasDerivedFrom
wikipedia-en:Brendan_Frey?oldid=981379954&ns=0
dbo:wikiPageLength
9324
dbo:birthName
Brendan John Frey
dbo:academicDiscipline
dbr:Computer_engineering dbr:Genome_biology dbr:Machine_learning
dbo:almaMater
dbr:University_of_Toronto
dbo:award
dbr:John_C._Polanyi dbr:Royal_Society_of_Canada
dbo:knownFor
dbr:Factor_Graphs dbr:Affinity_Propagation dbr:Genome_biology dbr:Wake-Sleep_Algorithm
dbo:residence
dbr:Canada
foaf:isPrimaryTopicOf
wikipedia-en:Brendan_Frey
Subject Item
dbr:Deep_learning
dbo:wikiPageWikiLink
dbr:Brendan_Frey
Subject Item
dbr:Geoffrey_Hinton
dbo:wikiPageWikiLink
dbr:Brendan_Frey
dbo:doctoralStudent
dbr:Brendan_Frey
Subject Item
wikipedia-en:Brendan_Frey
foaf:primaryTopic
dbr:Brendan_Frey